At the news
? MIXEDIMPACT 7/10 SC TO-T/A filed Nov 12, 2026 at 16:16 ET
Viatris and its wholly owned subsidiary Peach Purchaser Sub Inc. filed Amendment No. 1 to their Schedule TO, updating the litigation section to disclose two stockholder lawsuits and fifteen demand letters challenging the adequacy of disclosures in the $36.50 per share cash tender offer for Pacira BioSciences. The Pacira defendants intend to vigorously defend the actions, and the offer terms remain unchanged.
- Two stockholder complaints filed in New York Supreme Court alleging omitted/misrepresented information in Schedule 14D-9.
- Fifteen demand letters (including two draft complaints) received by Pacira seeking additional disclosures.
- Offer price remains $36.50 per share in cash, unchanged.
- Pacira defendants intend to vigorously defend the actions.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access